Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin heal… Read more
Solesence, Inc. Common Stock (SLSN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.146x
Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) has a cash flow conversion efficiency ratio of -0.146x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.51 Million) by net assets ($17.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Solesence, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Solesence, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Solesence, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solesence, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ChoA Pharmaceutical Co.Ltd
KQ:034940
|
0.052x |
|
Jindalee Lithium Ltd
AU:JLL
|
-0.060x |
|
Rubicon Organics Inc
OTCQX:ROMJF
|
0.010x |
|
Bookook Steel
KO:026940
|
-0.019x |
|
Yonggu Group Inc
TW:5546
|
0.032x |
|
Shimmick Corporation Common Stock
NASDAQ:SHIM
|
0.451x |
|
Skolon AB
ST:SKOLON
|
-0.796x |
|
Aiji net
KQ:462980
|
0.049x |
Annual Cash Flow Conversion Efficiency for Solesence, Inc. Common Stock (2021–2024)
The table below shows the annual cash flow conversion efficiency of Solesence, Inc. Common Stock from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $14.95 Million | $1.97 Million | 0.132x | +112.50% |
| 2023-12-31 | $1.90 Million | $-2.01 Million | -1.055x | -261.08% |
| 2022-12-31 | $5.65 Million | $-1.65 Million | -0.292x | -193.94% |
| 2021-12-31 | $7.46 Million | $2.32 Million | 0.311x | -- |